RecruitingNANCT07515118

An Artificial Intelligence Based Approach for Selecting the Optimal Day for Triggering.

Sponsor: Fundacion Dexeus

Trial Details

Condition	Infertility, Ovarian Stimulation, Artificial Intelligence
Intervention	STIMAI®.; Routine clinical management
Phase	NA
Status	Recruiting
Participants	644
Est. Completion	1 Apr 2027
Last Updated	22 Apr 2026

Primary Outcome

MII oocytes

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Undergoing COS for IVF with autologous oocytes, oocyte donation and elective fertility preservation with all monitoring USS (ultrasound scan) conducted at our centers. Exclusion Criteria: * Medically indicated fertility preservation * Inability to attend clinic visits for monitoring.

Trial Sites

Countries

Spain

View Registry Entry

Related Analysis

Phase III Trial Opens: AI-Guided vs Physician-Led Ovulation Triggering in IVF — What Reproductive Medicine Specialists Need to Know

A groundbreaking randomised trial in Spain is evaluating whether AI-guided ovulation triggering can match physician expertise in IVF cycles. The study of 644 participants compares STIMAI® technology against traditional clinical decision-making for optimal trigger timing.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service